Ursodiol Tablet
Product Images NDC 68462-474

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 68462-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of ursodiol, showing its molecular arrangement including multiple hydroxyl groups and a carboxyl group, consistent with its steroidal bile acid composition.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

250mgbottle (250mgbottle)

Ursodiol Tablets USP 250 mg oral tablets in a 100-tablet package. The label includes the NDC 68462-473-01 and is distributed by Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ. Storage instructions and an NDC barcode are visible on the label.*

FDA Label Image

500mglabel (500mglabel)

Ursodiol Tablets USP 500 mg oral tablets packaging label. The label states it is for the treatment of Primary Biliary Cirrhosis, contains 100 scored tablets, and is distributed by Glenmark Pharmaceuticals Inc., USA. It includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.